Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of the National Cancer Institute|August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group BD R Budman, D A Berry, C T Cirrincione, et al.European Journal of Pain (London, England)|April 23, 2004
Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group studyP Mucci-LoRusso, B S Berman, P T Silberstein, et al.Drug Intelligence & Clinical Pharmacy|December 1, 1987
Clearance of continuous intravenous morphine for severe cancer painM L Citron, J R Reynolds, W N Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
Combined therapy for stage III-IV head and neck cancer: preliminary resultsS H Krasnow, M H Cohen, A Johnston-Early, et al.Cancer Investigation|December 9, 1998
Long-term administration of controlled-release oxycodone tablets for the treatment of cancer painM L Citron, R Kaplan, W C Parris, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancerF A Holmes, S E Jones, J O'Shaughnessy, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2001
Smoking and lung cancer risk in American and Japanese men: an international case-control studyS D Stellman, T Takezaki, L Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup studyJ H Fetting, R Gray, D L Fairclough, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferaseM Belanich, T Randall, M A Pastor, et al.British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.Pageof 12